Clozapine prescribing in Germany: temporal trends and regional variations, 2012-2022. [PDF]
Scholle OHF +6 more
europepmc +1 more source
Acute Myocarditis: From Pathophysiology to Risk‐Stratified Management—A Clinical Review
Stepwise approach to patients with suspected acute myocarditis, integrating the 2024 American College of Cardiology (ACC) four‐stage classification (Stages A–D) and the 2025 European Society of Cardiology (ESC) inflammatory myopericardial syndrome (IMPS) framework. Step 1 (Initial Assessment): clinical presentation, first‐line investigations (ECG, high‐
Michele Golino +9 more
wiley +1 more source
Effects of Repeated Smoking and Quitting Cigarettes on Plasma Concentrations of Clozapine and Its N-Desmethyl and N-Oxide Metabolites in a Japanese Patient With Schizophrenia. [PDF]
Ikawa K +3 more
europepmc +1 more source
Differential Neuronal Development in iPSC-Derived Neural Stem Cells From Monozygotic Twin Cases With Treatment-Resistant Schizophrenia and Discordant Responses to Clozapine. [PDF]
Kawano S +13 more
europepmc +1 more source
Sustained Hematological Stability During Clozapine Rechallenge With Adjunctive Lithium: A Case Report of 15-Month Follow-Up. [PDF]
Hamda K +3 more
europepmc +1 more source
Enhancing Psychiatry Residents' Knowledge and Comfort With Clozapine Prescribing Through Educational Interventions. [PDF]
Stewart C +6 more
europepmc +1 more source
Potential of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Mitigating Metabolic Side Effects Associated With Clozapine or Olanzapine Therapy: A Literature Review. [PDF]
Meftah A +10 more
europepmc +1 more source
Risk factors associated with blood dyscrasia during clozapine treatment: a systematic review and meta-analysis. [PDF]
Casetta C +4 more
europepmc +1 more source
A scoping review of genetic studies of treatment-resistant schizophrenia. [PDF]
Das U +7 more
europepmc +1 more source

